Clinical Trials Browser

Interventional × Has results × ascrinvacumab × Clear all

NCT01337050 2015-10-28

Asian Phase I Study Of PF-03446962

Phase 1 Completed

36 enrolled 24 charts

Gastrointestinal

Carcinoma, Hepatocellular, Neoplasms

NCT01911273 2015-10-28

A Study To Evaluate The Efficacy And Safety of The Investigational Drug PF-03446962 (A Monoclonal Antibody With Antiangiogenic Features) In Combination With Best Supportive Care Versus Placebo Plus Best Supportive Care In Patients Affected By Recurrent Liver Cancer

Phase 2 Terminated

3 enrolled 4 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT00557856 2015-10-19

A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors

Phase 1 Completed

70 enrolled 22 charts

Other solid neoplasm

Advanced Solid Tumors